-
Health todayCancer refines
Cancer symptoms worsen faster in Ontario adults with severe psychiatric illness
Ontario adults with cancer and an inpatient history of severe psychiatric illness moved from mild to moderate pain at twice the rate of matched patients, and improved less often.
Peer-reviewed -
Data, models and systemsValue in health new
HPV-cytology co-testing is not cost-effective in Korean cervical cancer screening
HPV-cytology co-testing cost 100.5 to 118.4 million won per QALY over biennial cytology, 3.4 to 3.9 times Korea's threshold.
Peer-reviewed -
Health todayCancer refines
Germline genomic risk score adds to PSA in predicting prostate cancer outcomes
In 428,512 Million Veteran Program men, a genetic risk score predicted prostate cancer treatment, metastasis and biopsy findings beyond PSA.
Preprint · not peer-reviewed -
Health todayCancer refines
Early-onset colorectal cancer risk rises steeply across inherited risk groups
In UK Biobank under-50s, the top two inherited risk groups held 21% of people but 61% of early-onset colorectal cancers.
Peer-reviewed -
Health todayCancer confirms
GLP-1 receptor agonists and cancer risk in an umbrella review of 38 meta-analyses
In 48 placebo-controlled trials with 94 245 participants, GLP-1RAs showed no significant rise in overall or site-specific cancer.
Peer-reviewed -
Health todayCancer refines
PALB2 carriers found by exome sequencing have raised cancer risk and higher mortality
In two population cohorts, exome-identified PALB2 carriers had raised cancer risk and mortality, though below family-based estimates.
Peer-reviewed -
Health todayCancer refines
Distant-stage incidence and cancer mortality trends differ by site across ten US cancers
In US data for 2004-2023, distant-stage incidence rose for breast and prostate cancer and melanoma, while mortality fell.
Peer-reviewed -
Behavioural scienceDiet, exercise and sleep refines
Cardiorespiratory fitness and colorectal, lung and prostate cancer outcomes in men
In 28,612 men, higher treadmill-measured fitness was linked to lower colorectal and lung cancer risk, but not prostate cancer.
Peer-reviewed -
Health todayCancer refines
Targetable alterations in solid tumours often occur outside FDA-approved tumour types
Whole-genome sequencing of 17,029 primary and metastatic solid tumours found immediately actionable alterations in about a fifth to a quarter of cancers, and half of these variants lay in tumour types without FDA approval for that biomarker.
Peer-reviewed -
Health todayCancer refines
Branch-duct IPMN without worrisome features has raised pancreatic cancer incidence
In 1,234 Japanese patients with low-risk branch-duct IPMN, concomitant pancreatic ductal adenocarcinoma arose at 4.91 times the expected rate.
Peer-reviewed -
Health todayCancer refines
Solid second cancers after Hodgkin lymphoma in women fell as radiotherapy declined
In 7,428 women with Hodgkin lymphoma, solid second cancer risk fell 25% across eras, largely explained by reduced radiotherapy.
Peer-reviewed -
Data, models and systemsValue in health new
Biomarker-matched therapies for metastatic colorectal cancer are unfunded in Brazil
No biomarker-matched therapy for metastatic colorectal cancer is funded in Brazil's public system, and modelled costs are R$314,000-836,000 per QALY.
Peer-reviewed